These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37207874)

  • 1. Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
    Moral Nakamura D; da Graça Pinto H; Baena Elchin C; Thomazotti Berard L; Abreu Alves F; Azeredo Alves Antunes L; Pena Coto N
    Radiother Oncol; 2023 Sep; 186():109715. PubMed ID: 37207874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy.
    Gorsky M; Epstein JB; Parry J; Epstein MS; Le ND; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):190-5. PubMed ID: 14970777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
    Riley P; Glenny AM; Hua F; Worthington HV
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012744. PubMed ID: 28759701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does laser photobiomodulation prevent hyposalivation in patients undergoing head and neck radiotherapy? A systematic review and meta-analysis of controlled trials.
    Louzeiro GC; Teixeira DDS; Cherubini K; de Figueiredo MAZ; Salum FG
    Crit Rev Oncol Hematol; 2020 Dec; 156():103115. PubMed ID: 33039721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients.
    Jaguar GC; Lima EN; Kowalski LP; Pellizzon AC; Carvalho AL; Boccaletti KW; Alves FA
    Radiother Oncol; 2015 May; 115(2):253-6. PubMed ID: 25890572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
    Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced xerostomia in patients with head and neck cancer: a literature review.
    Dirix P; Nuyts S; Van den Bogaert W
    Cancer; 2006 Dec; 107(11):2525-34. PubMed ID: 17078052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
    Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
    Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bethanechol on salivary parameters in irradiated patients.
    Cotomacio C; Campos L; Simões A; Jaguar G; Crosato EM; Abreu-Alves F
    Med Oral Patol Oral Cir Bucal; 2017 Jan; 22(1):e76-e83. PubMed ID: 27918737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review.
    Zhuang L; Yang Z; Zeng X; Zhua X; Chen Z; Liu L; Meng Z
    Integr Cancer Ther; 2013 May; 12(3):197-205. PubMed ID: 22791311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.
    Lovelace TL; Fox NF; Sood AJ; Nguyen SA; Day TA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):595-607. PubMed ID: 24650370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
    de Castro G; Federico MH
    Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
    Nevens D; Nuyts S
    Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.
    Kaur H; Singh Banipal RP; Singh H; Sonik YA; Sandhu SK
    J Cancer Res Ther; 2023; 19(3):788-792. PubMed ID: 37470612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study.
    Epstein JB; Burchell JL; Emerton S; Le ND; Silverman S
    Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):610-4. PubMed ID: 7915026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of xerostomia in head and neck cancer patients.
    Nathan CO; Asarkar AA; Entezami P; Corry J; Strojan P; Poorten VV; Makitie A; Eisbruch A; Robbins KT; Smee R; St John M; Chiesa-Estomba C; Winter SC; Beitler JJ; Ferlito A
    Am J Otolaryngol; 2023; 44(4):103867. PubMed ID: 36996514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis.
    Sood AJ; Fox NF; O'Connell BP; Lovelace TL; Nguyen SA; Sharma AK; Hornig JD; Day TA
    Oral Oncol; 2014 Feb; 50(2):77-83. PubMed ID: 24189058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.